Is National Healthcare Corp. a growth stock? A data-driven read on its earnings momentum, price leadership, and demand, scored against every US stock from SEC filings and daily prices, and re-ranked after every close.
Yes, NHC fits the growth-stock profileAs of the 2026-07-27 close, NHC scores 94 out of 99 on our growth-stock rating, a textbook growth-stock leader. That ranks it 11th of 4,897 rated US stocks, the top 1% of the market.
Its strongest trait is C (current quarterly earnings) at 94, and its weakest is S (supply & demand) at 59. NHC clears 5 of the six core growth traits we score per stock; the seventh, overall market direction, is judged market-wide.
On price, NHC carries an elite Relative Strength rating of 94, meaning it has outperformed about 94% of the market over the past year.
Underneath the score: quarterly earnings up 10% year over year, sales up 2%, trading 1% below its 52-week high.
The six traits that separate real growth stocks from the rest: earnings, price leadership, and demand. Each is scored 1–99 against the whole US market. We compute them with the CANSLIM method, double-weighting earnings and relative strength.
| C | Current quarterly earnings most recent EPS growth vs. a year ago |
94 |
| A | Annual earnings growth multi-year earnings trend |
82 |
| N | New highs & catalysts proximity to new 52-week highs |
78 |
| S | Supply & demand volume behind the move vs. share supply |
59 |
| L | Leader or laggard Relative Strength within its group |
81 |
| I | Institutional sponsorship fund accumulation and 13F ownership |
73 |
NHC shows the earnings strength and price leadership that define a growth stock. That is what our screen flags, not a recommendation to buy. Timing and market direction still matter.
The stocks ranking above NHC today, the growth leaders you’d weigh against it.
Where NHC sits in its base, its 52-week path, and the trait trend over the past year.
Every US stock scored on the traits that define a growth stock and re-ranked after each close, with the top ranks, the full trait breakdown, and today’s market read.
Open the app, free through September 1Yes, NHC fits the growth-stock profile. NHC shows the earnings strength and price leadership that define a growth stock. That is what our screen flags, not a recommendation to buy. Timing and market direction still matter.
National Healthcare Corp. (NHC) scores 94 out of 99 on our growth-stock rating as of the 2026-07-27 close, ranking 11th of 4,897 rated US stocks.
NHC's most recent quarterly earnings were up about 10% year over year, with sales up 2%.
NHC has a Relative Strength rating of 94, meaning it has outperformed roughly 94% of the US market over the trailing year.
Create a free Growth Stock Analyzer account to see where NHC ranks against every US stock, the stronger growth stocks to weigh against it, and its full price and earnings history.
Want the method behind the score? Read how we grade growth stocks with CANSLIM.